Syn-1002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSyn-1002
Drug Alias NamePATPeptide analogue of thymulinSyn-1002
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPainCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsermCll Pharma
Active IndicationsN/A
Inactive IndicationsPainCrohn Disease

Other Information

ATC CodeN/A
Related LinksN/A